The Safety and Immunogenicity of a Potential HIV Vaccine
NCT01966900
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
BIOLOGICAL:
CN54gp140 mixed with GLA-AF
Sponsor
Imperial College London
Collaborators
[object Object]
[object Object]